HBV-IN-19 TFA

Modify Date: 2024-01-10 18:55:14

HBV-IN-19 TFA structure	Common Name	HBV-IN-19 TFA
	CAS Number	2241575-60-8	Molecular Weight	556.53
	Density	N/A	Boiling Point	N/A
	Molecular Formula	C₂₆H₃₁F₃N₂O₈	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of HBV-IN-19 TFA

HBV-IN-19 TFA inhibits hepatitis B virus (HBV) infection. Inhibiting HBsAg secretion and/or production is a strategy for the treatment of HBV infection, including chronic HBV infection[1].

Name	HBV-IN-19 TFA

Description	HBV-IN-19 TFA inhibits hepatitis B virus (HBV) infection. Inhibiting HBsAg secretion and/or production is a strategy for the treatment of HBV infection, including chronic HBV infection[1].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> HBV
References	[1]. Evangelos Aktoudianakis, et al. Compounds for the treatment of hepatitis b virus infection.WO2018144605A1.

Molecular Formula	C₂₆H₃₁F₃N₂O₈
Molecular Weight	556.53